(Q84848296)

English

Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function

scientific article published on 18 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Laura Chiossone

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Heba Abdelrazik

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Grazia M Spaggiari

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Lorenzo Moretta

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

18 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3281-3290

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells for therapeutic purposes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stromal cells: facilitators of successful transplantation?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet alpha-granules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells for clinical application

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of platelet lysate on the functional and molecular characteristics of mesenchymal stem cells isolated from adipose tissue.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host disease: Pathogenesis and clinical management.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells in allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterisation of CTL directed towards non-inherited maternal alloantigens in human cord blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

CD107a as a functional marker for the identification of natural killer cell activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141542

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201141542

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874650%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84848296&oldid=1447400071"